Croda completes acquisition of Avanti Polar Lipids

Press Release

13 August 2020

Croda completes acquisition of Avanti Polar Lipids

Croda International Plc ('Croda') today confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals. 

For further information see the announcement of the acquisition signing dated 6 July 2020. 

About Croda:

Croda is the speciality chemical company that creates high performance ingredients and technologies relied upon by industries and consumers globally. More at www.croda.com.

Further information:

Investors: David Bishop, Croda                                              +44 7823 874428

Media: Charlie Armitstead, Teneo                                          +44 7703 330269